Who makes Ethosomal gel bearing losartan 5%?

Ethosomal gel bearing losartan 5% is developed by Yuni Eka Anggraini.

What development phase is Ethosomal gel bearing losartan 5% in?

Ethosomal gel bearing losartan 5% is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Ethosomal gel bearing losartan 5%

Yuni Eka Anggraini · Phase 1 active Small molecule

At a glance

Generic name	Ethosomal gel bearing losartan 5%
Sponsor	Yuni Eka Anggraini
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ethosomal gel bearing losartan 5% CI brief — competitive landscape report
Ethosomal gel bearing losartan 5% updates RSS · CI watch RSS
Yuni Eka Anggraini portfolio CI